NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2-YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1674, Poster Board= SUN-037

Jonathan Barratt Poster Presenter